Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma
优化Elranatamab剂量以降低多发性骨髓瘤患者发生细胞因子释放综合征的风险
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-025-01134-8
Elmeliegy, Mohamed; Viqueira, Andrea; Vandendries, Erik; Hickman, Anne; Conte, Umberto; Irby, Donald; Hibma, Jennifer; Lon, Hoi-Kei; Piscitelli, Joseph; Soltantabar, Pooneh; Skoura, Athanasia; Jiang, Sibo; Wang, Diane